Insmed Incorporated - ROE
INSM
Price:
$95.8
Market Cap:
$20.76B
Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation...[Read more]
Industry
Biotechnology
IPO Date
2000-06-01
Stock Exchange
NASDAQ
Ticker
INSM
PE Ratio
[-16.63]
ROE
[-130.11%]
Current Ratio
[4.47]
Dividend Yield
[0%]
Enterprise Value
[20.93B]
Dividend History
The ROE as of June 2026 (TTM) for Insmed Incorporated (INSM) is -130.11%
According to Insmed Incorporated’s latest financial reports and current stock price. The company's current ROE is -130.11%. This represents a change of 292.71% compared to the average of -33.13% of the last 4 quarters.
Insmed Incorporated (INSM) Historical ROE (quarterly & annually)
How has INSM ROE performed in the past?
The mean historical ROE of Insmed Incorporated over the last ten years is -144.75%. The current -130.11% ROE has changed -10.11% with respect to the historical average. Over the past ten years (40 quarters), INSM's ROE was at its highest in in the September 2022 quarter at 437.75%. The ROE was at its lowest in in the June 2024 quarter at -774.41%.
Average
-144.75%
Median
-110.35%
Minimum
-547.50%
Maximum
225.83%
Insmed Incorporated (INSM) ROE by Quarter and Year
Discovering the peaks and valleys of Insmed Incorporated ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 417.04%
Maximum Annual ROE = 225.83%
Minimum Annual Increase = -241.79%
Minimum Annual ROE = -547.50%
| Year | ROE | Change |
|---|---|---|
| 2025 | -172.78% | -46.04% |
| 2024 | -320.20% | -241.79% |
| 2023 | 225.83% | -141.25% |
| 2022 | -547.50% | 417.04% |
| 2021 | -105.89% | -0.66% |
| 2020 | -106.60% | 9.67% |
| 2019 | -97.20% | -37.58% |
| 2018 | -155.70% | 191.82% |
| 2017 | -53.36% | -53.24% |
| 2016 | -114.11% | 200.94% |
Insmed Incorporated (INSM) Average ROE
How has INSM ROE performed in the past?
The current ROE of Insmed Incorporated (INSM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-89.05%
5-year avg
-184.11%
10-year avg
-144.75%
Insmed Incorporated (INSM) ROE vs. Peers
How is INSM’s ROE compared to its peers?
Insmed Incorporated’s ROE is less than BeOne Medicines Ltd. (12.10%), less than Agilent Technologies, Inc. (20.84%), less than ResMed Inc. (24.41%), less than IQVIA Holdings Inc. (22.46%), less than Alcon Inc. (3.69%), less than Haleon plc (6.43%), greater than Cardinal Health, Inc. (-55.72%), less than GE HealthCare Technologies Inc. (14.77%), less than Humana Inc. (6.19%), less than Takeda Pharmaceutical Company Limited (2.61%),
| Company | ROE | Market cap |
|---|---|---|
| 12.10% | $28.87B | |
| 20.84% | $35.89B | |
| 24.41% | $27.36B | |
| 22.46% | $28.00B | |
| 3.69% | $31.53B | |
| 6.43% | $39.55B | |
| -55.72% | $51.94B | |
| 14.77% | $28.02B | |
| 6.19% | $43.30B | |
| 2.61% | $49.39B |
Build a custom stock screener for Insmed Incorporated (INSM) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Insmed Incorporated using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Insmed Incorporated (INSM) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Insmed Incorporated or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Insmed Incorporated's ROE?
How is the ROE calculated for Insmed Incorporated (INSM)?
What is the highest ROE for Insmed Incorporated (INSM)?
What is the 3-year average ROE for Insmed Incorporated (INSM)?
What is the 5-year average ROE for Insmed Incorporated (INSM)?
How does the current ROE for Insmed Incorporated (INSM) compare to its historical average?